BioHarvest Sciences Inc.
BHSC
CNSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 20.11% | -11.06% | -91.49% | -14.34% | 8.85% |
| Total Depreciation and Amortization | 24.01% | 36.72% | 66.45% | 83.03% | 108.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -362.66% | -98.41% | 99.89% | -41.93% | -89.58% |
| Change in Net Operating Assets | 1,915.38% | -101.51% | 198.02% | -220.83% | 57.14% |
| Cash from Operations | 10.98% | -19.88% | -3.69% | -36.02% | -56.81% |
| Capital Expenditure | -7.35% | 18.36% | 30.05% | 23.41% | 6.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -7.35% | 18.36% | 30.05% | 23.41% | 6.52% |
| Total Debt Issued | 65.23% | 404.25% | -- | -- | -- |
| Total Debt Repaid | 5.80% | 10.59% | 7.38% | -8.13% | -31.14% |
| Issuance of Common Stock | -56.37% | -79.50% | -86.83% | -92.10% | -91.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 49.95% | 57.39% | 68.09% | -24.45% | -47.68% |
| Foreign Exchange rate Adjustments | 45.83% | 52.00% | -780.00% | -450.00% | -300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.30% | 126.10% | 79.40% | -202.01% | -213.87% |
